Xiang R - Search Results

1

MicroRNA-19a-3p inhibits breast cancer progression and metastasis by inducing macrophage polarization through downregulated expression of Fra-1 proto-oncogene.

Yang J, Zhang Z, Chen C, Liu Y, Si Q, Chuang TH, Li N, Gomez-Cabrero A, Reisfeld RA, Xiang R, Luo Y. Yang J, et al. Among authors: xiang r. Oncogene. 2014 Jun 5;33(23):3014-23. doi: 10.1038/onc.2013.258. Epub 2013 Jul 8. Oncogene. 2014. PMID: 23831570

2

Elimination of established murine colon carcinoma metastases by antibody-interleukin 2 fusion protein therapy.

Xiang R, Lode HN, Dolman CS, Dreier T, Varki NM, Qian X, Lo KM, Lan Y, Super M, Gillies SD, Reisfeld RA. Xiang R, et al. Cancer Res. 1997 Nov 1;57(21):4948-55. Cancer Res. 1997. PMID: 9354462

3

Targeted interleukin-2 therapy for spontaneous neuroblastoma metastases to bone marrow.

Lode HN, Xiang R, Varki NM, Dolman CS, Gillies SD, Reisfeld RA. Lode HN, et al. Among authors: xiang r. J Natl Cancer Inst. 1997 Nov 5;89(21):1586-94. doi: 10.1093/jnci/89.21.1586. J Natl Cancer Inst. 1997. PMID: 9362156

4

Natural killer cell-mediated eradication of neuroblastoma metastases to bone marrow by targeted interleukin-2 therapy.

Lode HN, Xiang R, Dreier T, Varki NM, Gillies SD, Reisfeld RA. Lode HN, et al. Among authors: xiang r. Blood. 1998 Mar 1;91(5):1706-15. Blood. 1998. PMID: 9473237 Free article.

5

Gene therapy with a single chain interleukin 12 fusion protein induces T cell-dependent protective immunity in a syngeneic model of murine neuroblastoma.

Lode HN, Dreier T, Xiang R, Varki NM, Kang AS, Reisfeld RA. Lode HN, et al. Among authors: xiang r. Proc Natl Acad Sci U S A. 1998 Mar 3;95(5):2475-80. doi: 10.1073/pnas.95.5.2475. Proc Natl Acad Sci U S A. 1998. PMID: 9482910 Free PMC article.

6

Recombinant immunocytokines targeting the mouse transferrin receptor: construction and biological activities.

Dreier T, Lode HN, Xiang R, Dolman CS, Reisfeld RA, Kang AS. Dreier T, et al. Among authors: xiang r. Bioconjug Chem. 1998 Jul-Aug;9(4):482-9. doi: 10.1021/bc980020e. Bioconjug Chem. 1998. PMID: 9667950

7

Induction of persistent tumor-protective immunity in mice cured of established colon carcinoma metastases.

Xiang R, Lode HN, Dreier T, Gillies SD, Reisfeld RA. Xiang R, et al. Cancer Res. 1998 Sep 1;58(17):3918-25. Cancer Res. 1998. PMID: 9731503

8

Suppression of human prostate carcinoma metastases in severe combined immunodeficient mice by interleukin 2 immunocytokine therapy.

Dolman CS, Mueller BM, Lode HN, Xiang R, Gillies SD, Reisfeld RA. Dolman CS, et al. Among authors: xiang r. Clin Cancer Res. 1998 Oct;4(10):2551-7. Clin Cancer Res. 1998. PMID: 9796990

9

Immunocytokines: a promising approach to cancer immunotherapy.

Lode HN, Xiang R, Becker JC, Gillies SD, Reisfeld RA. Lode HN, et al. Among authors: xiang r. Pharmacol Ther. 1998 Dec;80(3):277-92. doi: 10.1016/s0163-7258(98)00033-3. Pharmacol Ther. 1998. PMID: 9888698 Review.

10

Synergy between an antiangiogenic integrin alphav antagonist and an antibody-cytokine fusion protein eradicates spontaneous tumor metastases.

Lode HN, Moehler T, Xiang R, Jonczyk A, Gillies SD, Cheresh DA, Reisfeld RA. Lode HN, et al. Among authors: xiang r. Proc Natl Acad Sci U S A. 1999 Feb 16;96(4):1591-6. doi: 10.1073/pnas.96.4.1591. Proc Natl Acad Sci U S A. 1999. PMID: 9990069 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,131 results

Search Page

Filters